retatrutide phase 2 nejm 2023 obesity trial jastreboff SURPASS-2 (NEJM 2021) was the definitive head-to-head: tirzepatide vs semaglutide 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type diabetes. All three tirzepatide doses produced superior HbA1c reductions GLP-1 Medications for Weight Loss:

For example, Roberts has found that even moving some runs from the mornings to the afternoons can help athletes on weight-loss meds who need more time to digest their previous nights meal

Mental Health Challenges: The social stigma associated with obesity can lead to depression, anxiety, and a lower quality of life

Chng li cc tc hi ca gc t do, ngn chn hnh thnh np nhn, gip ln cng bng v ti tr hn

By pairing clear evidence with empathetic listening, clinicians can foster shared decision-making, build trust, and help patients thoughtfully consider therapies endorsed by professional guidelines

When another cause needs attention Persistent rash may reflect allergy, infection, medication reaction, inflammatory skin disease, essential-fatty-acid deficiency or another medical condition